Interaction between replication forks and topoisomerase I-DNA cleavable complexes

Studies in a cell-free SV40 DNA replication system

Yeou Ping Tsao, Leroy-Fong Liu, Gill Nyamuswa, Robert Silber, Leroy F. Liu

Research output: Contribution to journalArticle

203 Citations (Scopus)

Abstract

The extreme S-phase-specific cytotoxicity of camptothecin has been shown to involve active DNA replication. To investigate the role of DNA replication in camptothecin cytotoxicity, we have studied the interaction between the DNA replication machinery and the topoisomerase I-camptothecin-DNA ternary cleavable complex in a cell-free SV40 DNA replication system. The formation of topoisomerase I-camptothecin-DNA-cleavable complexes on the replication template efficiently and irreversibly inhibited DNA replication. Two aberrant forms of replication products were produced whose abundance varied with the concentrations of exogenously added topoisomerase I and camptothecin. At low concentrations of topoisomerase I and camptothecin, the major aberrant DNA replication product was close-to-unit-length-linear DNA, while at higher concentrations the predominant product was close-to-dimer-size-linear DNA. Analysis of these aberrant replication products has suggested a "collision" model in which the interaction between an advancing replication fork and a topoisomerase I-camptothecin-DNA-cleavable complex results in irreversible arrest of the replication fork and the formation of a double-strand DNA break at the fork. Concomitant with fork arrest and fork breakage, the reversible cleavable complex was converted into a topoisomerase I-linked DNA break. We propose that one or several of these events triggers S-phase-specific cell killing and G2-phase cell cycle arrest.

Original languageEnglish
Pages (from-to)5908-5914
Number of pages7
JournalCancer Research
Volume53
Issue number24
Publication statusPublished - Dec 15 1993
Externally publishedYes

Fingerprint

Camptothecin
Type I DNA Topoisomerase
DNA Replication
S Phase
G2 Phase Cell Cycle Checkpoints
DNA Breaks
Double-Stranded DNA Breaks
G2 Phase
DNA

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Interaction between replication forks and topoisomerase I-DNA cleavable complexes : Studies in a cell-free SV40 DNA replication system. / Tsao, Yeou Ping; Liu, Leroy-Fong; Nyamuswa, Gill; Silber, Robert; Liu, Leroy F.

In: Cancer Research, Vol. 53, No. 24, 15.12.1993, p. 5908-5914.

Research output: Contribution to journalArticle

Tsao, Yeou Ping ; Liu, Leroy-Fong ; Nyamuswa, Gill ; Silber, Robert ; Liu, Leroy F. / Interaction between replication forks and topoisomerase I-DNA cleavable complexes : Studies in a cell-free SV40 DNA replication system. In: Cancer Research. 1993 ; Vol. 53, No. 24. pp. 5908-5914.
@article{f60755929e9b4036b37966eeec7c8a95,
title = "Interaction between replication forks and topoisomerase I-DNA cleavable complexes: Studies in a cell-free SV40 DNA replication system",
abstract = "The extreme S-phase-specific cytotoxicity of camptothecin has been shown to involve active DNA replication. To investigate the role of DNA replication in camptothecin cytotoxicity, we have studied the interaction between the DNA replication machinery and the topoisomerase I-camptothecin-DNA ternary cleavable complex in a cell-free SV40 DNA replication system. The formation of topoisomerase I-camptothecin-DNA-cleavable complexes on the replication template efficiently and irreversibly inhibited DNA replication. Two aberrant forms of replication products were produced whose abundance varied with the concentrations of exogenously added topoisomerase I and camptothecin. At low concentrations of topoisomerase I and camptothecin, the major aberrant DNA replication product was close-to-unit-length-linear DNA, while at higher concentrations the predominant product was close-to-dimer-size-linear DNA. Analysis of these aberrant replication products has suggested a {"}collision{"} model in which the interaction between an advancing replication fork and a topoisomerase I-camptothecin-DNA-cleavable complex results in irreversible arrest of the replication fork and the formation of a double-strand DNA break at the fork. Concomitant with fork arrest and fork breakage, the reversible cleavable complex was converted into a topoisomerase I-linked DNA break. We propose that one or several of these events triggers S-phase-specific cell killing and G2-phase cell cycle arrest.",
author = "Tsao, {Yeou Ping} and Leroy-Fong Liu and Gill Nyamuswa and Robert Silber and Liu, {Leroy F.}",
year = "1993",
month = "12",
day = "15",
language = "English",
volume = "53",
pages = "5908--5914",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "24",

}

TY - JOUR

T1 - Interaction between replication forks and topoisomerase I-DNA cleavable complexes

T2 - Studies in a cell-free SV40 DNA replication system

AU - Tsao, Yeou Ping

AU - Liu, Leroy-Fong

AU - Nyamuswa, Gill

AU - Silber, Robert

AU - Liu, Leroy F.

PY - 1993/12/15

Y1 - 1993/12/15

N2 - The extreme S-phase-specific cytotoxicity of camptothecin has been shown to involve active DNA replication. To investigate the role of DNA replication in camptothecin cytotoxicity, we have studied the interaction between the DNA replication machinery and the topoisomerase I-camptothecin-DNA ternary cleavable complex in a cell-free SV40 DNA replication system. The formation of topoisomerase I-camptothecin-DNA-cleavable complexes on the replication template efficiently and irreversibly inhibited DNA replication. Two aberrant forms of replication products were produced whose abundance varied with the concentrations of exogenously added topoisomerase I and camptothecin. At low concentrations of topoisomerase I and camptothecin, the major aberrant DNA replication product was close-to-unit-length-linear DNA, while at higher concentrations the predominant product was close-to-dimer-size-linear DNA. Analysis of these aberrant replication products has suggested a "collision" model in which the interaction between an advancing replication fork and a topoisomerase I-camptothecin-DNA-cleavable complex results in irreversible arrest of the replication fork and the formation of a double-strand DNA break at the fork. Concomitant with fork arrest and fork breakage, the reversible cleavable complex was converted into a topoisomerase I-linked DNA break. We propose that one or several of these events triggers S-phase-specific cell killing and G2-phase cell cycle arrest.

AB - The extreme S-phase-specific cytotoxicity of camptothecin has been shown to involve active DNA replication. To investigate the role of DNA replication in camptothecin cytotoxicity, we have studied the interaction between the DNA replication machinery and the topoisomerase I-camptothecin-DNA ternary cleavable complex in a cell-free SV40 DNA replication system. The formation of topoisomerase I-camptothecin-DNA-cleavable complexes on the replication template efficiently and irreversibly inhibited DNA replication. Two aberrant forms of replication products were produced whose abundance varied with the concentrations of exogenously added topoisomerase I and camptothecin. At low concentrations of topoisomerase I and camptothecin, the major aberrant DNA replication product was close-to-unit-length-linear DNA, while at higher concentrations the predominant product was close-to-dimer-size-linear DNA. Analysis of these aberrant replication products has suggested a "collision" model in which the interaction between an advancing replication fork and a topoisomerase I-camptothecin-DNA-cleavable complex results in irreversible arrest of the replication fork and the formation of a double-strand DNA break at the fork. Concomitant with fork arrest and fork breakage, the reversible cleavable complex was converted into a topoisomerase I-linked DNA break. We propose that one or several of these events triggers S-phase-specific cell killing and G2-phase cell cycle arrest.

UR - http://www.scopus.com/inward/record.url?scp=0027139317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027139317&partnerID=8YFLogxK

M3 - Article

VL - 53

SP - 5908

EP - 5914

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 24

ER -